{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:14:02Z","timestamp":1784139242874,"version":"3.55.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.juro.2015.02.043","type":"journal-article","created":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T07:00:46Z","timestamp":1423897246000},"page":"46-51","source":"Crossref","is-referenced-by-count":25,"title":["Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen Screening"],"prefix":"10.1097","volume":"194","author":[{"given":"Jonathan","family":"Gelfond","sequence":"first","affiliation":[{"name":"Department of Biostatistics and Epidemiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas"},{"name":"Department of Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Choate","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna P.","family":"Ankerst","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas"},{"name":"Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas"},{"name":"Department of Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas"},{"name":"Department of Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Leach","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas"},{"name":"Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas"},{"name":"Department of Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas"},{"name":"Department of Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.02.043_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2015.02.043_bib2","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2015.02.043_bib3","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.juro.2009.01.029","article-title":"Yearly\u00a0prostate specific antigen and digital rectal examination fluctuations in a screened population","volume":"181","author":"Ankerst","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.02.043_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating\u00a0characteristics of prostate-specific antigen in men with an initial PSA level of 3.0\u00a0ng\/ml or lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2015.02.043_bib5","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2015.02.043_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1370\/afm.942","article-title":"Cumulative incidence of false-positive results in repeated, multimodal cancer screening","volume":"7","author":"Croswell","year":"2009","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.juro.2015.02.043_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2015.02.043_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early\u00a0detection of prostate cancer: AUA Guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.02.043_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cncr.28373","article-title":"The cost implications of prostate cancer screening in the Medicare population","volume":"120","author":"Ma","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2015.02.043_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.2006.06.9351","article-title":"Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years","volume":"25","author":"Lilja","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2015.02.043_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2011.07.067","article-title":"Baseline prostate-specific antigen testing at a young age","volume":"61","author":"Loeb","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.02.043_bib12","doi-asserted-by":"crossref","first-page":"c4521","DOI":"10.1136\/bmj.c4521","article-title":"Prostate\u00a0specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study","volume":"341","author":"Vickers","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.juro.2015.02.043_bib13","doi-asserted-by":"crossref","first-page":"g2296","DOI":"10.1136\/bmj.g2296","article-title":"Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study","volume":"348","author":"Carlsson","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.juro.2015.02.043_bib14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/pros.20417","article-title":"The\u00a0distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening","volume":"66","author":"Porter","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2015.02.043_bib15","first-page":"21","article-title":"Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents","volume":"12","author":"Bennette","year":"2012","journal-title":"BMC"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471500292X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471500292X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.02.043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:04:43Z","timestamp":1651205083000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.02.043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1016\/j.juro.2015.02.043"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.02.043","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}